BRPI1011710A8 - lágrimas artificiais e usos trapêuticos - Google Patents
lágrimas artificiais e usos trapêuticos Download PDFInfo
- Publication number
- BRPI1011710A8 BRPI1011710A8 BRPI1011710A BRPI1011710A BRPI1011710A8 BR PI1011710 A8 BRPI1011710 A8 BR PI1011710A8 BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 A8 BRPI1011710 A8 BR PI1011710A8
- Authority
- BR
- Brazil
- Prior art keywords
- oil
- artificial tears
- traumatic
- syndrome
- dog
- Prior art date
Links
- 239000000607 artificial tear Substances 0.000 title abstract 3
- 230000000472 traumatic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- 239000008162 cooking oil Substances 0.000 abstract 1
- 239000002285 corn oil Substances 0.000 abstract 1
- 235000005687 corn oil Nutrition 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
- 239000004006 olive oil Substances 0.000 abstract 1
- 235000008390 olive oil Nutrition 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"lágrimas artificiais e usos trapêuticos". a presente invenção refere-se a composições oftálmicas, por exemplo lágrimas artificiais, apropriadas para o tratamento da síndrome do olho seco em um ser humano ou outro mamífero sofrendo de tal síndrome, por exemplo, um cachorro ou gato, que compreende uma mistura de óleo de mamona com outro óleo, por exemplo, um óleo alimentício, por exemplo azeite de oliva, óleo de gergelim, óleo de milho e etc.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18433909P | 2009-06-05 | 2009-06-05 | |
| US61/184,339 | 2009-06-05 | ||
| PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| BRPI1011710A2 BRPI1011710A2 (pt) | 2016-03-22 |
| BRPI1011710A8 true BRPI1011710A8 (pt) | 2019-11-05 |
| BRPI1011710B1 BRPI1011710B1 (pt) | 2021-01-26 |
| BRPI1011710B8 BRPI1011710B8 (pt) | 2021-05-25 |
Family
ID=42312750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1011710A BRPI1011710B8 (pt) | 2009-06-05 | 2010-06-03 | composição para ser usada como uma lágrima artificial |
Country Status (24)
| Country | Link |
|---|---|
| US (7) | US8496976B2 (pt) |
| EP (1) | EP2437762B1 (pt) |
| KR (1) | KR101778316B1 (pt) |
| CN (2) | CN104906170A (pt) |
| AU (1) | AU2010256652B2 (pt) |
| BR (1) | BRPI1011710B8 (pt) |
| CA (1) | CA2764802A1 (pt) |
| DK (1) | DK2437762T3 (pt) |
| ES (1) | ES2646338T3 (pt) |
| HK (1) | HK1214943A1 (pt) |
| HR (1) | HRP20171691T1 (pt) |
| HU (1) | HUE034213T2 (pt) |
| IL (1) | IL216800A (pt) |
| LT (1) | LT2437762T (pt) |
| MX (2) | MX2011013007A (pt) |
| MY (1) | MY172185A (pt) |
| NO (1) | NO2437762T3 (pt) |
| NZ (1) | NZ596932A (pt) |
| PL (1) | PL2437762T3 (pt) |
| PT (1) | PT2437762T (pt) |
| RU (1) | RU2589837C2 (pt) |
| SI (1) | SI2437762T1 (pt) |
| WO (1) | WO2010141648A2 (pt) |
| ZA (1) | ZA201108979B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| ES2646338T3 (es) | 2009-06-05 | 2017-12-13 | Allergan, Inc. | Lágrimas artificiales y usos terapéuticos |
| US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| DK2787968T3 (da) * | 2011-12-07 | 2020-06-02 | Allergan Inc | Effektiv lipidlevering til menneskelig tårefilm under anvendelse af et saltsensitivt emulsionssystem |
| US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
| US10085960B2 (en) | 2012-03-30 | 2018-10-02 | Brien Holden Vision Institute | Methods and compositions for reducing ocular discomfort |
| US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
| WO2016029034A1 (en) | 2014-08-20 | 2016-02-25 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
| MX372988B (es) * | 2014-11-25 | 2020-04-06 | Allergan Inc | Composiciones oftalmicas estabilizadas de omega 3. |
| WO2017066429A1 (en) | 2015-10-14 | 2017-04-20 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
| JP2019519596A (ja) | 2016-04-08 | 2019-07-11 | コーネル・ユニバーシティーCornell University | シルク由来タンパク質を使用して創傷治癒を増進する方法 |
| WO2019005139A1 (en) * | 2017-06-30 | 2019-01-03 | Jenivision Inc. | FORMULATIONS FOR HAIR GROWTH |
| JOP20170147B1 (ar) * | 2016-07-07 | 2021-08-17 | Salvat Lab Sa | تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة |
| MX2019001633A (es) | 2016-08-12 | 2019-09-18 | Silk Tech Ltd | Proteina derivada de la seda para el tratamiento de la inflamacion. |
| CA3032695C (en) * | 2016-08-19 | 2021-11-23 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
| GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
| JP7311160B2 (ja) | 2017-08-18 | 2023-07-19 | アクリビスタ エルエルシー | ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 |
| WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
| BR112021000634A2 (pt) | 2018-07-27 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
| WO2020021480A2 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
| CN112739337B (zh) | 2018-07-27 | 2024-05-24 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
| US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
| US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
| KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
| EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
| US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| CN112823789B (zh) | 2019-11-19 | 2024-05-10 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
| EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
| US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| ATE109970T1 (de) | 1987-09-03 | 1994-09-15 | Univ Georgia Res Found | Cyclosporin-augenmittel. |
| US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
| BE1003578A4 (fr) * | 1988-10-26 | 1992-04-28 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine. |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| WO1997024129A1 (en) | 1995-12-27 | 1997-07-10 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
| US5981607A (en) | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
| GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
| US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
| JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
| UY28126A1 (es) * | 2002-12-24 | 2004-06-30 | Alcon Inc | Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular |
| US8992974B2 (en) * | 2003-02-24 | 2015-03-31 | Pharmaceuticals Productions, Inc. | Transmucosal drug delivery system |
| US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
| US20060251685A1 (en) | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
| US20060009522A1 (en) | 2004-07-01 | 2006-01-12 | Reza Dana | Compositions and methods for treating eye disorders and conditions |
| US20070265353A1 (en) * | 2004-08-27 | 2007-11-15 | Senju Pharmaceutical Co., Ltd. | Eye Drops for the Treatment of Dry Eye |
| US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
| US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
| US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
| US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
| WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
| WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
| CN101668511A (zh) * | 2007-02-28 | 2010-03-10 | 阿西克斯医疗公司 | 正常化睑板腺分泌的方法和化合物 |
| CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
| UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
| IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
| ES2646338T3 (es) | 2009-06-05 | 2017-12-13 | Allergan, Inc. | Lágrimas artificiales y usos terapéuticos |
-
2010
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
- 2010-06-03 HR HRP20171691TT patent/HRP20171691T1/hr unknown
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko not_active Expired - Fee Related
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en not_active Abandoned
-
2024
- 2024-10-25 US US18/926,912 patent/US20250082709A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1011710A8 (pt) | lágrimas artificiais e usos trapêuticos | |
| BR112012006692A2 (pt) | composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas | |
| ECSP12012211A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
| BR112013007314A2 (pt) | anticorpos anti-cd48 e seus usos | |
| EA202091999A3 (ru) | Применение ингибиторов dpp iv | |
| BR112014033102A2 (pt) | produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido | |
| BRPI0918139A2 (pt) | composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso | |
| ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
| UA109271C2 (uk) | Комбінація фітоканабіноїдів та темозоламіду для лікування гліоми | |
| CO6571886A2 (es) | Antagonistas de pcsk9 | |
| BRPI0808775A2 (pt) | compostos e composições como moduladores de atividade de gpr119 | |
| MX358617B (es) | Formulaciones de inhibidores de dpp iv. | |
| IL186741A0 (en) | Optical probe for delivery of light | |
| BR112012005835A2 (pt) | alteração da temperatura em um corpo de mamífero | |
| ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| GT200600254A (es) | Moduladores de aminoquinolina y aminoquinazolina quinasa | |
| MX2009012645A (es) | Formulaciones y metodos para tratar el ojo seco. | |
| IN2012DN03178A (pt) | ||
| BRPI0919013A2 (pt) | Dispositivo e sistema de implante pélvico | |
| BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
| BR112014011481A2 (pt) | hidrolisado de colágeno e seu uso | |
| BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
| BR112013004562A2 (pt) | 2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3 | |
| BR112012015386B8 (pt) | composição oftálmica tópica | |
| CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |